Sponsor:
Sir Mortimer B. Davis - Jewish General Hospital
Code:
NCT02355171
Conditions
Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Brief summary:
Conditions
Cancer
Study ID
NCT02355171
Start date
Nov, 2015
Status verified date
Nov, 2026
Completion date
Dec, 2030
Anticipated
Primary completion date
Dec, 2030
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
20000 participants
Anticipated
Primary outcome measure
Central contacts
Locations
Jewish General Hospital University Health Centre
Recruiting
Montreal, Quebec, Canada, H3T 1E2
Contacts
Principal Investigator:
Mark Basik, MD
Sponsor
Sir Mortimer B. Davis - Jewish General Hospital
Last update posted
Nov 5, 2026
Last verified
Nov, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-06. This information was provided to ClinicalTrials.gov by Sir Mortimer B. Davis - Jewish General Hospital on 2026-11-05. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.